Skip to content

APOTHEEK JOHAN COPPENS: what changed

What changed

APOTHEEK JOHAN COPPENS

BE 0894.208.059
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€41,755
2024 · -€25,696-€16,059
Equity
€10,675
2024 · €52,430-€41,755
Cash
€32,202
2024 · €41,644-€9,442
Balance sheet total
€248,919
2024 · €192,972+€55,947

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€29,958

    up €29,958 (+172%), from €17,394 to €47,352

    of which Trade receivables: +€30,305

  • Current investments +€25,163

    new in 2025: €25,163

  • Cash -€9,442

    down €9,442 (-22.7%), from €41,644 to €32,202

    mainly Net result for the year (-€41,755) and Receivables within one year (-€29,958)

  • Deferred charges and accrued income +€5,958

    up €5,958 (+18.7%), from €31,868 to €37,826

  • Stocks and contracts +€4,587

    up €4,587 (+5.3%), from €85,834 to €90,421

Equity and liabilities
  • Other debts +€90,135

    up €90,135 (+150%), from €59,998 to €150,133

  • Profit (loss) carried forward -€41,755

    down €41,755 (-158%), from -€26,492 to -€68,247

  • Tax, wage and social debts +€6,593

    up €6,593 (+72.9%), from €9,040 to €15,633

    of which Remuneration and social security: +€6,196

Income statement
  • Staff costs +€39,046

    up €39,046 (+50.5%), from €77,369 to €116,415

  • Gross operating margin +€22,463

    up €22,463 (+37.0%), from €60,747 to €83,211

  • Depreciation -€931

    down €931 (-13.0%), from €7,172 to €6,241

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€25,696
Gross operating margin +€22,463
Staff costs -€39,046
Depreciation +€931
Other operating charges -€173
Financial income -€251
Financial charges +€22
Taxes -€5
Result 2025 -€41,755
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€21,685
Investment -€31,126
Financing €0
Cash 2024 €41,644
Net result for the year -€41,755
Depreciation +€6,241
Stocks and contracts -€4,587
Receivables within one year -€29,958
Deferred charges and accrued income -€5,958
Trade debts +€1,127
Tax, wage and social debts +€6,593
Other debts +€90,135
Accrued charges and deferred income -€153
Investment in fixed assets (net) -€5,964
Current investments -€25,163
Cash 2025 €32,202
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €192,972 €248,919 +€55,947 +29.0%
Fixed assets 21/28 €16,232 €15,955 -€277 -1.7%
Tangible fixed assets 22/27 €16,232 €15,955 -€277 -1.7%
Plant, machinery and equipment 23 €10,079 €6,289 -€3,790 -37.6%
Furniture and vehicles 24 - €5,367 +€5,367
Other tangible fixed assets 26 €6,153 €4,298 -€1,855 -30.1%
Current assets 29/58 €176,740 €232,964 +€56,224 +31.8%
Stocks and contracts in progress 3 €85,834 €90,421 +€4,587 +5.3%
Stocks 30/36 €85,834 €90,421 +€4,587 +5.3%
Amounts receivable within one year 40/41 €17,394 €47,352 +€29,958 +172%
Trade receivables 40 €13,663 €43,968 +€30,305 +222%
Other amounts receivable 41 €3,731 €3,384 -€347 -9.3%
Current investments 50/53 - €25,163 +€25,163
Cash at bank and in hand 54/58 €41,644 €32,202 -€9,442 -22.7%
Deferred charges and accrued income 490/1 €31,868 €37,826 +€5,958 +18.7%
Total equity and liabilities 10/49 €192,972 €248,919 +€55,947 +29.0%
Equity 10/15 €52,430 €10,675 -€41,755 -79.6%
Contributions 10/11 €78,000 €78,000 = 0.0%
Reserves 13 €922 €922 = 0.0%
Tax-exempt reserves 132 €63 €63 = 0.0%
Distributable reserves 133 €859 €859 = 0.0%
Profit (loss) carried forward 14 -€26,492 -€68,247 -€41,755 -158%
Amounts payable 17/49 €140,542 €238,244 +€97,702 +69.5%
Amounts payable after more than one year 17 €10,000 €10,000 = 0.0%
Financial debts 170/4 €10,000 €10,000 = 0.0%
Amounts payable within one year 42/48 €128,003 €225,858 +€97,855 +76.4%
Trade debts 44 €58,965 €60,092 +€1,127 +1.9%
Suppliers 440/4 €58,965 €60,092 +€1,127 +1.9%
Taxes, remuneration and social security 45 €9,040 €15,633 +€6,593 +72.9%
Taxes 450/3 €1,431 €1,828 +€397 +27.7%
Remuneration and social security 454/9 €7,609 €13,805 +€6,196 +81.4%
Other amounts payable 47/48 €59,998 €150,133 +€90,135 +150%
Accrued charges and deferred income 492/3 €2,539 €2,386 -€153 -6.0%
Remuneration, social security and pensions 62 €77,369 €116,415 +€39,046 +50.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,172 €6,241 -€931 -13.0%
Other operating charges 640/8 €2,474 €2,647 +€173 +7.0%
Gross operating margin 9900 €60,747 €83,211 +€22,463 +37.0%
Operating profit (loss) 9901 -€26,268 -€42,092 -€15,824 -60.2%
Financial income 75/76B €963 €712 -€251 -26.1%
Recurring financial income 75 €963 €712 -€251 -26.1%
Financial charges 65/66B €233 €211 -€22 -9.3%
Recurring financial charges 65 €233 €211 -€22 -9.3%
Profit (loss) for the period before taxes 9903 -€25,537 -€41,591 -€16,054 -62.9%
Income taxes 67/77 €159 €164 +€5 +3.2%
Profit (loss) for the period 9904 -€25,696 -€41,755 -€16,059 -62.5%
Profit (loss) for the period to be appropriated 9905 -€25,696 -€41,755 -€16,059 -62.5%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.